https://www.avient.com/resources/safety-data-sheets?page=4331
Geon(TM) V1341-81 TOP COAT BELTING - GRAY
https://www.avient.com/sites/default/files/2021-02/avient-canada-ulc-qst-number-2.4.2021.pdf
Registration number 1019288451 TQ 0004
Status Valid
Effective date of status 2017-08-01
Date viewed 2021-02-04
Business's name AVIENT CANADA ULC
Business name SPARTECH PLASTIQUES
Registration number to validate
1019288451TQ0004
Page 1 of 1Validate a QST Registration Number - Revenu Québec
2/4/2021https://entreprises.revenuquebec.ca/EntNa/SX/SX00/SX00.SXCLT20A.ValiderInscription/...
https://www.avient.com/sites/default/files/2023-09/Avient Sustainability Day 2023 - Website %289.19%29.pdf
September 20, 2023
(NYSE: AVNT)Avient
Sustainability Day
AGENDA
WELCOME
Bob Patterson
INTRODUCTION
Jamie Beggs
SUSTAINABILITY STRATEGY
Walter Ripple
SUSTAINABLE SOLUTIONS
Michael Garratt, Chris Pederson, Woon Keat Moh
SUMMARY
Jamie Beggs
WRAP UP AND Q+A
Bob Patterson
Avient Corporation 2
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
DISCLAIMER
Avient Corporation 3
Avient Corporation 4
Welcome
Bob Patterson
Chairman, President, and Chief Executive Officer
INTRODUCTION
Sustainability for a Better Tomorrow
Jamie Beggs
Senior Vice President and Chief Financial Officer
Avient Corporation 5
WE ARE A FORMULATOR
CUSTOM
FORMULATION
Avient Corporation 6
Avient Corporation 7
WE ARE INNOVATORS
2,500+
ACTIVE PATENT
FILINGS WORLDWIDE
1,100+
RESEARCH AND
DEVELOPMENT ASSOCIATES
>85% Stage-gate technology projects enable sustainable solutions
INDIA INNOVATION CENTER
33%
2022 VITALITY
INDEX
140+
MATERIAL SCIENCE
PhD ASSOCIATES
Avient Corporation 8
3% 3%
5%
Avient Specialty Formulators Other Specialty /
Chemical Companies
CAPEX / Revenue
2023E
Global footprint enables greater flexibility to exceed
needs of customers and deliver localized technical
and formulation expertise
35
9
36
24
Manufacturing Locations by Region
WE ARE ASSET LIGHT
Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA
Avient Corporation 9
Asset-light flexibility
enables more nimble
manufacturing capabilities
and lower overhead
Periods of economic
weakness have driven
higher levels of cash
generation due to working
capital improvement
PROVEN TRACK RECORD OF HIGH FREE CASH FLOW CONVERSION
78%
78%
80% 80%
81%
78%
84%
83%
80%
79%
50%
55%
60%
65%
70%
75%
80%
85%
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023E
0
50
100
150
200
250
300
350
400
Fr
ee
C
as
h
Fl
ow
C
on
ve
rs
io
n
Fr
ee
C
as
h
Fl
ow
FC F $ AVNT FC F Conver si on % S&P F CF Conversion %
2 Recent Divestitures - Combined $1.7B in Proceeds
PORTFOLIO EVOLUTION
Avient Corporation 10
Combined $3.6B Investment in Acquisitions Since 2016
Color Business
Distribution
2016 2022
PORTFOLIO TRANSFORMATION
7%
46%
66%
87%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2020 2023
%
o
f A
dj
us
te
d
EB
IT
D
A
Commodity JVs Distribution Performance Products & Solutions Specialty Businesses
Adjusted EBITDA from Specialty Applications
Avient Corporation 11
END MARKET TRANSFORMATION
Packaging
Consumer
Healthcare
Defense
Avient Corporation 12
10%
19%
8%
23%
4%
7%
7%
2006 2023E
Other
Industri
es
78%
Healthcare
Consumer
Packaging
22%
56%
14%
10%
43%
9%
2006 2023E
Reduced Exposure to Cyclical End Markets End Market Diversification
Transportation
Building &
Construction
57%
19%
Defense
IMPROVING PROFITABILITY AND EXPANDING MARGINS
Avient Corporation 13
Adj.
Per Carlsson, Manufacturing and Operations
CUSTOMER
TESTIMONIALS
Avient Corporation 71
50
90
0
20
40
60
80
100
2022 2030
Medical Plastics Market Size
PRESERVE – TAKEAWAY
Protecting Human Life and Enabling Connectivity Drives Growth Projections
Examples
Covered
Today
56%
Other Applications
44%
2022
$525M (i
n
$B
ill
io
ns
)
8% CAGR 34% CAGR
5G Infrastructure Market Size
12
92
0
10
20
30
40
50
60
70
80
90
100
2023 2024 2025 2026 2027 2028 2029 2030
(in
$
B
ill
io
ns
)
Source: Grand View Research Source: Global Data
Summary
Jamie Beggs
Senior Vice President and Chief Financial Officer
Avient Corporation 72
OUR SUSTAINABILITY REPORT
Avient Corporation 73
Avient Corporation 74
2030 SUSTAINABILITY GOALS
Avient Corporation 75
PERFORMANCE AND RECOGNITION
1
2
5
ESG Ratings Performance
ESG Awards and Certifications
top 13%
94th
percentile
Avient Corporation 76
SUSTAINABILITY INNOVATION AWARDS
Ultra-Low Carbon
Footprint TPE
Innovation Award, Finalist:
Plastics Industry Association
PCR Colorants + Additives
Sustainable Packaging Innovation,
Finalist: U.S.
https://www.avient.com/sites/default/files/2023-08/AVNT August IR Presentation w NonGAAP Recs%5B40%5D.pdf
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
A U G U S T 2 0 2 3
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
expectations:
US & Canada
LATAM
EMEA
Asia
• Net price benefit remains greater
than wage and energy inflation
• Clariant synergies and reduced
administrative costs
Q2 2 023 SEQUENTI AL SAL ES BY REGI ON
Q 2 2 0 2 3 v s .
Avient reflects 2023 adjusted EBITDA guidance of $525M and estimated run-rate CAPEX of $110M.
2023E (%)
27
79
89
83 83
78
75
90
81
76
72
68
63
53
11
A
vi
e
n
t
K
W
R
F
U
L
P
P
G
A
V
Y
R
P
M
F
M
C
C
E
E
C
L
A
S
H
H
X
L
H
U
N
E
M
N
S
C
L
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
MULTI PL E EX PANSION
Source: Peer data per Bloomberg as of August 17, 2023
Note: Avient reflects 2023 adjusted EBITDA guidance of $525M and closing share price of $37.07.
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
Microsoft PowerPoint - Avient March IR - Fermium
AVIENT CORPORATION
(NYSE: AVNT)
M A R C H 1 8 , 2 0 2 1
I R M E E T I N G S
H O S T E D B Y
F E R M I U M R E S E A R C H
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
24
Capex / Revenue
2021E (%)
AV I E N T I S A SS E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3
2 2 3 3
3
4 3 3 4
4 4 5 5
5 5
7 7 8
23
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
SEGMENT HIGHLIGHTS
U.S. & Canada
50%
EMEA
26%
Asia
16%
Latin America
8%
2020 SEGMENT, END MARKET AND GEOGRAPHY
29
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
23%
Packaging
21%Industrial
15%
Wire & Cable
6%
Building &
Construction
6%
Electrical &
Electronics
4%
END MARKET REVENUE
Transportation
10%
Healthcare
15%
All data reflects 2020 Pro forma for acquisition of the Clariant Masterbatch business.
(1) The total company sales and EBITDA of $3,783M and $457M, respectively, include intercompany sales eliminations and corporate costs
$2,043M
$331M
$709M
$124M
$1,110M
$70M
Sales EBITDA
Distribution
Specialty Engineered Materials
Color Additives and Inks
$457M$3,783M
(1)
Packaging
35%
Consumer
23%
Healthcare
8%
Industrial
14%
Building &
Construction
8%
Transportation
7%
Wire & Cable
3%
Electrical &
Electronics
2%
C O L O R , A D D I T I V E S & I N K S
2 0 2 0 P F R E V E N U E | $ 2 . 0 B I L L I O N
US & Canada
31%
EMEA
40%
Asia
22%
Latin America
7%
END MARKET REGION
30
2020 figures Pro forma for acquisition of the Clariant Masterbatch business
S P E C I A L T Y E N G I N E E R E D M A T E R I A L S
Consumer
24%
Healthcare
10%
Packaging
6%
Wire & Cable(1)
24%
Electrical &
Electronics
13%
Transportation
11%
Industrial
10%
Building &
Construction
2%
2 0 2 0 R E V E N U E | $ 7 0 9 M I L L I O N
END MARKET
US & Canada
58%
EMEA
23%
Asia
19%
REGION
31
(1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling
D I S T R I B U T I O N
2 0 2 0 R E V E N U E | $ 1 . 1 B I L L I O N
Healthcare
29%
Consumer
25%
Packaging
2%
Industrial
20%
Transportation
14%
Electrical &
Electronics
5%
Building &
Construction
4%
Wire & Cable
1%
US & Canada
82%
Asia
3%
Latin
America
15%
END MARKET REGION
K E Y S U P P L I E R S
32
AMERICAS EMEA ASIA
Consumer
26%
Healthcare
19%
Packaging
13%
Industrial
16%
Wire & Cable
7%
Building &
Construction
5%
Electrical &
Electronics
4%
Packaging
34%
Consumer
16%Healthcare
5%
Industrial
17%
Wire & Cable
10%
Building &
Construction
8%
Electrical &
Electronics
3%
Packaging
32%
Consumer
27%
Healthcare
12%
Industrial
6%
Wire & Cable
6%
Building &
Construction
4%
Electrical &
Electronics
9%
Transportation
10%
Transportation
7%
Transportation
4%
2020 figures Pro forma for acquisition of the Clariant Masterbatch business
T O T A L C O M PA N Y R E G I O N A L S A L E S
B Y E N D M A R K E T
(58% of sales) (26% of sales) (16% of sales)
33
https://www.avient.com/sites/default/files/2023-06/AVNT June IR Conferences w_Non GAAP Recs.pdf
Microsoft PowerPoint - AVNT June IR Conferences_6.1.2023 1130AM
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
J U N E 2 0 2 3
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
2023E(%)
37
79
89
83 81
76
73
90
82
77 76 74
70
58
22
A
vi
e
n
t
K
W
R
P
P
G
F
U
L
A
V
Y
R
P
M
F
M
C
C
E
H
X
L
A
S
H
E
C
L
H
U
N
E
M
N
S
C
L
M U LT I P L E E X PA N S I O N
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
Source: Peer data per Bloomberg as of May 31, 2023
Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $36.50.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years.
38
EV / 2023E EBITDA
Historic Multiple
6.5
8.3
9.6
13.2 13.0 12.8
11.3
8.6
17.9
16.8
10.7
8.8 8.8 8.7
7.5
6.9
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
8
)
A
vi
e
n
t
(2
0
2
3
)
K
W
R
P
P
G
R
P
M
A
V
Y
F
U
L
E
C
L
H
X
L
F
M
C
S
C
L
C
E
A
S
H
E
M
N
H
U
N
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
AVIENT CORPORATION
(NYSE: AVNT)
N O V E M B E R 2 0 2 0
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
17
Capex / Revenue
2021E (%)
Source: Bloomberg market data as of November 9, 2020
AV I E N T I S A S S E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3 2 2 3 3
3
6
3 4
5 5 5 5
5 6 6
7
7
9
24
A
v
ie
n
t
A
v
ie
n
t
(E
x
c
l.
SEGMENT HIGHLIGHTS
Packaging
37%
Consumer
22%
Healthcare
8%
Industrial
14%
Building &
Construction
8%
Transportation
6%
Wire & Cable
3%
Electrical &
Electronics
2%
C O L O R , A D D I T I V E S & I N K S
2 0 2 0 P F R E V E N U E | $ 2 . 0 B I L L I O N
$9
$320
2005 2020PF
2.0%
15.9%
2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business
US & Canada
32%
Europe
39%
Asia
23%
Latin America
6%
END MARKET REGION EBITDA DOLLAR & MARGIN
EXPANSION
24
$5
$120
2005 2020E
US & Canada
59%
Europe
23%
Asia
18%
Consumer
23%
Healthcare
10%
Packaging
6%
Wire & Cable(1)
25%
Electrical &
Electronics
14%
Industrial
10%
Transportation
10%
Building &
Construction
2%
S P E C I A L T Y E N G I N E E R E D M A T E R I A L S
2 0 2 0 E R E V E N U E | $ 7 0 0 M I L L I O N
0.9%
17.1%
END MARKET REGION EBITDA DOLLAR & MARGIN
EXPANSION
25
(1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling
Healthcare
30%
Consumer
24%Packaging
3%
Industrial
19%
Transportation
15%
Electrical &
Electronics
4%
Building &
Construction
4%
Wire & Cable
1%
US & Canada
79%
Asia
2%
Latin
America
19%
END MARKET REGION EBITDA DOLLAR & MARGIN
EXPANSION
D I S T R I B U T I O N
2 0 2 0 E R E V E N U E | $ 1 . 1 B I L L I O N
$20
$70
2005 2020E
2.9%
6.3%
K E Y S U P P L I E R S
26
AMERICAS EUROPE ASIA
Consumer
26%
Healthcare
19%
Packaging
13%
Industrial
16%
Wire & Cable
7%
Building &
Construction
5%
Electrical &
Electronics
4%
Packaging
35%
Consumer
14%Healthcare
6%
Industrial
17%
Wire & Cable
10%
Building &
Construction
8%
Electrical &
Electronics
3%
Packaging
32%
Consumer
26%
Healthcare
12%
Industrial
7%
Wire & Cable
6%
Building &
Construction
4%
Electrical &
Electronics
9%
Transportation
10%
Transportation
7%
Transportation
4%
2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business
T O T A L C O M PA N Y R E G I O N A L S A L E S
B Y E N D M A R K E T
(58% of sales) (25% of sales) (17% of sales)
27
https://www.avient.com/sites/default/files/2023-11/AVNT November IR Presentation.pdf
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
N O V E M B E R 2 0 2 3
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M.
2023E (%)
27
78
89
84 82 80 77
88
81
76
70 69
60
54
(6)
A
vi
en
t
K
W
R
FU
L
P
P
G
A
V
Y
R
P
M
FM
C
C
E
E
C
L
A
S
H
H
X
L
H
U
N
E
M
N
S
C
L
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
MULTIPLE EXPANSION
Source: Peer data per Bloomberg as of October 27, 2023
Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $31.18.
Avient 2011, 2018 and 2021 multiples reflect trailing 12 months EBITDA at December 31.
28
EV / 2023E EBITDA
6.5
8.5
11.0
8.9
12.0 11.9
10.9
9.9
8.2
16.3
13.8
11.9
9.6 9.5 9.5 9.2
7.7
20
11
20
18
20
21
O
ct
20
23
A
V
Y
R
P
M
P
P
G
K
W
R
FU
L
E
C
L
H
X
L
S
C
L
A
S
H
FM
C
C
E
H
U
N
E
M
N
Avient Historic Multiple
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
A P P E N D I X
30
Performance
Additives
16%
Pigments
12%
TiO2
10%
Dyestuffs
2%
Polyethylene
11%
Nylon
6%
Polypropylene
5%
Styrenic Block
Copolymer
5%
Other Raw
Materials
33%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
2022 pro forma results for the acquisition of Avient Protective Materials
RA W MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
40%
EMEA
37%
Asia
18%
Latin America
5%
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
20%
Packaging
24%
Industrial
15%
Building and
Construction
10%
Telecommunications
4%
Energy
4%
Defense
6%
END MARKET REVENUE
$2,355M $402M
$1,300M $272M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$592M$3,653M
(1)
Transportation
9%
Healthcare
8%
32
(1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N
US & Canada
34%
EMEA
38%
Asia
20%
Latin America
8%
END MARKET REGION
33
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
8%
Building &
Construction
11%
Telecommunications
1% Energy
2%
COLOR, ADDITIVES & INKS
2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
34
Packaging
5%
Consumer
19%
Healthcare
8%Industrial
16%
Transportation
10%
Telecommunications
10%
Energy
9% Defense
15%
Building &
Construction
8%
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
Packaging
32%
Consumer
27%
Healthcare
8%
Industrial
14%
Building &
Construction
5%
Telecommunications
3%
Energy
1% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S
Packaging
27%
Consumer
14%
Healthcare
5%
Industrial
17%
Building &
Construction
10%
Energy
5%
Defense
8%
EMEA
(37% of sales)Transportation
11%
Packaging
13%
Consumer
24%
Healthcare
12%
Industrial
15%
Building &
Construction
13%
Energy
5%
Defense
5%
US &
Canada
(40% of sales)
Transportation
7%
Packaging
56%
Consumer
23%
Healthcare
4%
Industrial
7%
Building &
Construction
4%
Telecommunications
1%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
3%
Telecommunications
6%
35
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-earnings-presentation_0.pdf
Microsoft PowerPoint - AVNT Q3 2021 Earnings Presentation - WEBSITE
AVIENT CORPORATION
T H I R D Q U A R T E R 2 0 2 1 R E S U L T S
(NYSE: AVNT)
O C T O B E R 2 8 , 2 0 2 1
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
This
innovation drives performance and is
reflective of consistent, strategic
investments in technology and people
Clariant Color business
acquired July 1, 2020
1
1
2
3
5
7
7
7
9
10
30
40
14
25
13
22
35
9
19
13
18
41
Current Additional share needed to reach 2025 target
B R A N D O W N E R S C O M M I T T E D TO I N C R E A S I N G
U S E O F R E C YC L E D M AT E R I A L S
8
Brand Owner 1
Brand Owner 3
Brand Owner 2
Brand Owner 7
Brand Owner 4
Brand Owner 10
Brand Owner 6
Brand Owner 11
Brand Owner 5
Brand Owner 8
Brand Owner 9
Brand Owner 12
Brand Owner 13
Percent recycled plastic used:
(examples and not exhaustive)
(1)
(1) Latest year reported.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
22
Capex / Revenue
2021E (%)
AV I E N T I S A SS E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3
1
2
3 3
3
4
3 3
5 5 5
5
6
8
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Credit%2520Suisse%2520-%2520June%25202015.pdf
PolyOne Corporation Page 1
PolyOne Investor Presentation
Credit Suisse
Boston Basic Materials Conference
June 2015
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
S&P 500
PolyOne Corporation Page 9
2006 Q1 2015 2020
“Where we were” “Where we are” Platinum Vision
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 16.2% 20%+
Global Specialty Engineered
Materials 1.1% 16.3% 20%+
Designed Structures & Solutions 1.4% (2012) 2.7% 12 – 14%
Performance Products &
Solutions 5.5% 6.5% 10 – 12%
Distribution 2.6% 5.9% 6.5 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 69% 80%+
3) ROIC 5.0% 11.4% 15%
4) Adjusted EPS Growth N/A
22 Consecutive
Quarters of
EPS Growth
Double Digit
Expansion
Proof of Performance & 2020 Goals
PolyOne Corporation Page 10
Platinum Vision: Pathway to Accelerated Growth
Organic
Sales Growth
Margin
Expansion
Share
Repurchases
Acquisitions
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
6
9
7
3
5
12
5 3 2
8
4
2
4
3
1
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 14 8 18 12 22 74
Addressable Market
($ millions)
$700 $600 $600 $1,900
PolyOne Corporation Page 14
60%
98%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q1 2015
Pension Funding**
As of March 31, 2015
Debt Maturities & Pension Funding
Net Debt / EBITDA* = 2.1x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2015
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2015
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20
$0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased over
500k shares in Q1
2015
Repurchased 11.8
million shares since
early 2013
8.2 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Platform
operating
income
mix
percentage 2005* 2006* 2007* 2008* 2009* 2010* 2011 2012 2013 2014 2015 Q1
Global Color,
Additives and
Inks
$ 4.3 $ 8.9 $ 25.7 $ 28.1 $ 25.2 $ 37.7 $ 50.2 $ 75.3 $ 104.0 $ 124.9 $ 33.8
Global
Specialty
Engineered
Materials
0.4 3.9 4.9 17.6 20.6 49.7 45.9 47.0 57.2 72.4 23.1
Designed
Structures and
Solutions
- - - - - - - - 33.4 45.1 3.2
Specialty
Platform $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 96.1 $ 122.3 $ 194.6 $ 242.4 $ 60.1
Performance
Products and
Solutions
75.7 64.2 65.8 31.3 33.1 54.0 27.7 38.8 56.0 63.1 11.5
Distribution 19.5 19.2 22.1 28.1 24.8 42.0 56.0 66.0 63.3 68.2 15.7
Joint ventures 91.9 102.9 34.8 28.6 25.5 18.9 5.0 - - - -
Corporate and
eliminations (51.5) 34.5 (73.3) (425.1) 7.9 (27.7) 18.2 (89.6) (82.4) (218.6) (17.2)
Operating
income (loss)
GAAP
$ 140.3 $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 203.0 $ 137.5 $ 231.5 $ 155.1 $ 70.1
Less:
Corporate
operating
expense
51.5 (34.5) 73.3 425.1 (7.9) 27.7 (18.2) 89.6 82.4 218.6 17.2
Operating
income
excluding
Corporate
$ 191.8 $ 199.1 $ 153.3 $ 133.7 $ 129.2 $ 202.3 $ 184.8 $ 227.1 $ 313.9 $ 373.7 $ 87.3
Specialty
platform
operating mix
percentage
2% 6% 20% 34% 35% 43% 52% 54% 62% 65% 69%
* Historical results have not been restated for the Resin business divestiture or the related resegmentation.
2
Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y
Net income attributable to
PolyOne common
shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0
Joint venture equity earnings,
after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - -
Special items, after tax(1) (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7 30.4 101.0
Tax adjustments(2) (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5 2.2 (10.5)
Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5
Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5
Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80
Adjusted EPS 2010 Q1 2011 Q1 2012 Q1 2013 Q1 2014 Q1 2015 Q1
Net income attributable to PolyOne common shareholders $ 20.1 $ 106.0 $ 15.3 $ 11.2 $ 29.4 $ 30.2
Joint venture equity earnings, after tax (0.5) (3.7) - - - -
Special items, after tax(1) (0.3) (79.8) 6.1 17.2 14.1 5.5
Tax adjustments(2) (3.5) (1.5) 0.1 0.5 (1.6) 5.9
Adjusted net income $ 15.8 $ 21.0 $ 21.5 $ 28.9 $ 41.9 $ 41.6
Diluted shares 95.3 96.4 90.7 92.8 95.7 90.1
Adjusted EPS $ 0.17 $ 0.22 $ 0.24 $ 0.31 $ 0.44 $ 0.46
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal or discontinued operations